Robin Desmarais
Seekonk,MA
Summary
Tenured, high performing Senior Sales Professional in the biotech/Orphan Market. Experience includes Rare/ Orphan disease, biotech in Cardiology, Endocrinology, Pulmonology, Rheumatology, Pediatric Neurology, Hematology, Oncology as well as Nephrology. Extremely successful working with cross- functional Matrix Team. Results driven professional. Patient Centric. Multiple President's club winner, Circle of Excellence Winner. Significant experience working with Specialty Pharmacy as well as Patient Support Groups. Over 9 years working with REMS products. Extensive product launch experience.
Overview
26
26
years of professional experience
Work History
Regional Account Manager-Duchenne Muscular Dystrophy
PTC Therapeutics, Inc
08.2018 - Current
- Responsible for Market Development and Reimbursement Management for Emflaza in the Duchenne Muscular Dystrophy space
- Work in a cross-functional team with Case managers, Market Access, Patient Engagement and Medical team
- Market development for AADC-Gene therapy
- Ranked #1 in Nation for 2020
- Exceeded 2019 goal, achieving 102%, while nation at 96%
- Awarded Rookie of the Year for 2018
- Received Peer Recognition Award for 2021
- Ranked #5 in Nation for 2022
- Regional Field Trainer 2021 & 2024
- Served on Marketing Advisory Board
- Participating in Market Access internship
- Member Academy of Managed Care Pharmacists (AMCP)-National and Northeast chapters, attend all regional and national AMCP meetings
Acthar Sales Specialist-Autoimmune & Rare Disease Division
Mallinckrodt Pharmaceuticals
01.2017 - 08.2018
- Responsible for market development of Acthar, an orphan biologic in Nephrotic Syndrome (Membranous Nephropathy, Focal Segmental Glomerulosclerosis, Lupus Nephritis and Minimal Change Disease) in the Boston Academic Centers
- Responsible for KOL Development
- Ranked #2 in Northeast Region for 3rd Quarter 2017 at 112% to goal
- Ranked #1 in Northeast Region for 4th Quarter 2017 at 183% to goal
- Exceeded 2017 goal, achieving 103% while Nation at 91%.
Senior Rare Disease Manager
Aegerion Pharmaceuticals, Inc
09.2013 - 01.2017
- Responsible for the launch of Juxtapid and Myalept in the New England Territory, inclusive of all Academic Centers in Boston as well as New York
- Developed Regional and Nationa Key Opinion Leaders
- Education and management of all community and academic Cardiology, Endocrinology and Lipidology programs, including patient education and adherence responsibilities
- Served on Myalept product launch team
- Served on Myalept Marketing Advisory board
- Field Sales Trainer for Myalept/Juxtapid
- Ranked #6 out of 55 in the Nation for Myalept 2015
- Ranked #10 out of 55 in the Nation for Juxtapid 2015
- Achieved the 1st Myalept prescription in the US, 1 week post launch
- Promoted to Senior Rare Disease Manager, January 2016.
Territory Manager/District Training Liaison
Actelion Pharmaceuticals
08.2008 - 09.2013
- Responsible for promoting Tracleer, Ventavis and Veletri to Cardiologists, Pulmonologists and Rheumatologist's in an orphan disease market
- Exceeded goals for both Tracleer and Ventavis every year since hire
- Winner of Meet at the Top 2011 & 2012
- Winner of Circle of Excellence 2012
- Nominated for Circle of Excellence 2011 & 2012
- Ranked #1 for Tracleer and Ventavis for 2011 & 2012
- Winner of the Fab 15 Tracleer Contest 2011
- Winner of the Shining Star Award 2011
- Developed 4 new PAH clinics in the territory since 2008.
Senior Medical Center Specialist/District Sales Trainer
Sanofi-Aventis
01.1999 - 08.2008
- Responsible for educating physicians, residents, and nurses on the benefits of Lovenox within the Hematology, Oncology, Cardiology and Pulmonary markets.
- Achieved Regional All-Star for multiple years
- Member of Lovenox Marketing Team for Medical Prophylaxis
- Finished 2002 #1 out of 11 representatives in the Boston South District
- Maintained a 96% market share for Lovenox in Rhode Island increasing competition
- Effectively promote the 8 FDA-approved indications for Lovenox
- Effectively trained new representatives.
Territory Manager
Kos Pharmaceuticals
12.1997 - 04.1999
- Successfully launched Niaspan in Massachusetts/Rhode Island
- Responsible for educating residents and lipid experts in major teaching institutions
- Gained formulary acceptance for Niaspan on Compass Medical Formulary
- Increased Niaspan market share 200%.
Education
B.S. in Business Administration -
Bryant University
Smithfield, RISkills
- Business development
- Rare Disease
- Strategic planning
- Relationship building
- Account Servicing
- Market Analysis
- Product Launch
- REMS
- Market Access
Timeline
Regional Account Manager-Duchenne Muscular Dystrophy
PTC Therapeutics, Inc
08.2018 - Current
Acthar Sales Specialist-Autoimmune & Rare Disease Division
Mallinckrodt Pharmaceuticals
01.2017 - 08.2018
Senior Rare Disease Manager
Aegerion Pharmaceuticals, Inc
09.2013 - 01.2017
Territory Manager/District Training Liaison
Actelion Pharmaceuticals
08.2008 - 09.2013
Senior Medical Center Specialist/District Sales Trainer
Sanofi-Aventis
01.1999 - 08.2008
Territory Manager
Kos Pharmaceuticals
12.1997 - 04.1999
B.S. in Business Administration -
Bryant University
Similar Profiles
Gregory C. HoughtonGregory C. Houghton
Director, Intellectual Property at PTC TherapeuticsDirector, Intellectual Property at PTC Therapeutics
Cheri SpaventaCheri Spaventa
Senior Manager, IT Project Management at PTC THERAPEUTICSSenior Manager, IT Project Management at PTC THERAPEUTICS
Anthony TurpoffAnthony Turpoff
Associate Manager at PTC TherapeuticsAssociate Manager at PTC Therapeutics
Alexa SoaresAlexa Soares
para professional at Sacred Heart Schoolpara professional at Sacred Heart School
Kailyn Gridley-CraigKailyn Gridley-Craig
Shift Leader at Dunkin' DonutsShift Leader at Dunkin' Donuts